Robert Verkerk

Kynurenine pathway in major depression: Evidence of impaired neuroprotection

Aye-Mu Myint, Yong Ku Kim, Robert Verkerk et al. · Journal of Affective Disorders · 2006 · 520 citations

Psychiatry, Medicine, Subcortical Ischemic Depression +8

IDO and interferon-α-induced depressive symptoms: a shift in hypothesis from tryptophan depletion to neurotoxicity

Marieke Wichers, Ger H. Koek, Geert Robaeys et al. · Molecular Psychiatry · 2004 · 440 citations

Psychoneuroimmunology, Neuropsychology, Psychiatry +13

Increased Depressive Ratings in Patients With Hepatitis C Receiving Interferon-α–Based Immunotherapy Are Related to Interferon-α–Induced Changes in the Serotonergic System

Stefania Bonaccorso, Valentina Marino, Antonella Puzella et al. · Journal of Clinical Psychopharmacology · 2002 · 427 citations

Extended Structure–Activity Relationship and Pharmacokinetic Investigation of (4-Quinolinoyl)glycyl-2-cyanopyrrolidine Inhibitors of Fibroblast Activation Protein (FAP)

Koen Jansen, Leen Heirbaut, Robert Verkerk et al. · Journal of Medicinal Chemistry · 2014 · 264 citations · Full text

Structure–activity Relationship, Drug Target, Cellular Pharmacology +17

The inflammatory response system and the availability of plasma tryptophan in patients with primary sleep disorders and major depression

Cai Song, Aihua Lin, Stefania Bonaccorso et al. · Journal of Affective Disorders · 1998 · 235 citations

Inflammation, Sleep Disorders, Sleep +12